These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 25749987
1. A correlation between decreased parathyroid α-Klotho and fibroblast growth factor receptor 1 expression with pathological category and parathyroid gland volume in dialysis patients. Yan J, Jingbo C, Wang D, Xie S, Yuan L, Zhong X, Hao L. Int Urol Nephrol; 2015 Apr; 47(4):701-6. PubMed ID: 25749987 [Abstract] [Full Text] [Related]
4. Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients. Komaba H, Goto S, Fujii H, Hamada Y, Kobayashi A, Shibuya K, Tominaga Y, Otsuki N, Nibu K, Nakagawa K, Tsugawa N, Okano T, Kitazawa R, Fukagawa M, Kita T. Kidney Int; 2010 Feb; 77(3):232-8. PubMed ID: 19890272 [Abstract] [Full Text] [Related]
6. Parathyroidectomy in patients with chronic kidney disease: Impacts of different techniques on the biochemical and clinical evolution of secondary hyperparathyroidism. Albuquerque RFC, Carbonara CEM, Martin RCT, Dos Reis LM, do Nascimento CP, Arap SS, Moysés RMA, Jorgetti V, Montenegro FLM, de Oliveira RB. Surgery; 2018 Feb; 163(2):381-387. PubMed ID: 29146232 [Abstract] [Full Text] [Related]
7. Decreased parathyroid Klotho expression is associated with persistent hyperparathyroidism after kidney transplantation. Hong YA, Choi DE, Lim SW, Yang CW, Chang YK. Transplant Proc; 2013 Oct; 45(8):2957-62. PubMed ID: 24157012 [Abstract] [Full Text] [Related]
11. Does the downregulation of the FGF23 signaling pathway in hyperplastic parathyroid glands contribute to refractory secondary hyperparathyroidism in CKD patients? Lafage-Proust MH. Kidney Int; 2010 Mar; 77(5):390-2. PubMed ID: 20150940 [Abstract] [Full Text] [Related]
12. Persistent alpha-Klotho (a-Kl) expression in the parathyroid glands of patients with secondary hyperparathyroidism. Ohkido I, Yokoyama K, Imura A, Utsunomiya Y, Hosoya T, Nabeshima Y. Nephrol Dial Transplant; 2010 Mar; 25(3):1007-8; author reply 1008-9. PubMed ID: 20075437 [No Abstract] [Full Text] [Related]
13. [Optical and ultrastructural morphology in hyperparathyroidism during dialysis]. Schiaffino E, Zogno C, Schmid C, Mangili F, Cantaboni A. Pathologica; 1992 Mar; 84(1092):445-58. PubMed ID: 1491886 [Abstract] [Full Text] [Related]
14. Clinical features and hyperplastic patterns of parathyroid glands in hemodialysis patients with advanced secondary hyperparathyroidism refractory to maxacalcitol treatment and required parathyroidectomy. Tominaga Y, Matsuoka S, Sato T, Uno N, Goto N, Katayama A, Haba T, Kazuharu Uchida (Yagoto PTx Forum). Ther Apher Dial; 2007 Aug; 11(4):266-73. PubMed ID: 17661832 [Abstract] [Full Text] [Related]
16. Differential expression and regulation of Klotho by paricalcitol in the kidney, parathyroid, and aorta of uremic rats. Ritter CS, Zhang S, Delmez J, Finch JL, Slatopolsky E. Kidney Int; 2015 Jun; 87(6):1141-52. PubMed ID: 25692955 [Abstract] [Full Text] [Related]
19. Efficacy of percutaneous ethanol injection therapy (PEIT) is related to the number of parathyroid glands in haemodialysis patients with secondary hyperparathyroidism. Koiwa F, Kakuta T, Tanaka R, Yumita S. Nephrol Dial Transplant; 2007 Feb; 22(2):522-8. PubMed ID: 17127701 [Abstract] [Full Text] [Related]